Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Luca Miele, Antonio Lanzone, Maurizio Pompili, Rosanna Apa, Francesca Sagnella, Daniela Martinez, Francesca Moro, Andrea Morciano, Consuelo Cefalo

Research output: Contribution to journal › Article

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences